FDA Focuses on Fosamax

Agency conducts a safety review of osteoporosis drug's possible side effects.
3:00 | 03/11/10

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for FDA Focuses on Fosamax

This transcript has been automatically generated and may not be 100% accurate.

{"id":10071166,"title":"FDA Focuses on Fosamax","duration":"3:00","description":"Agency conducts a safety review of osteoporosis drug's possible side effects.","section":"GMA","mediaType":"Default"}